Clinical course of patients with idiopathic Parkinson's disease
Identifieur interne : 001349 ( Istex/Corpus ); précédent : 001348; suivant : 001350Clinical course of patients with idiopathic Parkinson's disease
Auteurs : Roos ; J. C. F. Jongen ; E. A. Van Der VeldeSource :
- Movement Disorders [ 0885-3185 ] ; 1996-05.
English descriptors
- KwdEn :
Abstract
We determined the variables associated with the progression and duration of illness of patients with Parkinson's disease (PD) and investigated the cause of death. In 474 patients with parkinsonism, who visited the Academic Hospital between January 1, 1960 and August 31, 1993, we did a survival analysis with the following covariates: age at onset, intial symptom (tremor or rigidity/hypokinesia), age at reaching Hoehn and Yahr stage III, dementia‐free period, and levodopa treatment. A total of 345 patients with parkinsonism fulfilled the criteria of idiopathic PD; 258 of them were still alive on the closing date of this study. There were significantly more men than women (1.43:1). Medical advice was sought in an earlier stage by men and by patients with tremor as presenting symptom. For patients with rigidity/hypokinesia as first symptom, the duration of illness until reaching Hoehn and Yahr stage III was shorter than for patients starting with tremor alone. If the initial symptom is tremor, patients develop dementia less frequently and later after onset than when tremor is not involved. Reaching Hoehn and Yahr stage III and developing dementia both, limit the patient's survival time. The mortality risk for a patient was found to be increased form the moment levodopa treatment was started as compared to those patients who had not yet started with the treatment. The effect of levodopa on survival could not be disentangled from effects of other factors related to the start of levodopa treatment.
Url:
DOI: 10.1002/mds.870110304
Links to Exploration step
ISTEX:E0A2124D53BF6D7E0B6BE559FB3C7F723821814BLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical course of patients with idiopathic Parkinson's disease</title><author><name sortKey="Roos" sort="Roos" uniqKey="Roos" last="Roos">Roos</name><affiliation><mods:affiliation>Department of Neurology, Leiden University, Leiden, the Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Jongen, J C F" sort="Jongen, J C F" uniqKey="Jongen J" first="J. C. F." last="Jongen">J. C. F. Jongen</name><affiliation><mods:affiliation>Department of Neurology, Leiden University, Leiden, the Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Van Der Velde, E A" sort="Van Der Velde, E A" uniqKey="Van Der Velde E" first="E. A." last="Van Der Velde">E. A. Van Der Velde</name><affiliation><mods:affiliation>Department of Medical Statistics, Leiden University, Leiden, the Netherlands</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:E0A2124D53BF6D7E0B6BE559FB3C7F723821814B</idno><date when="1996" year="1996">1996</date><idno type="doi">10.1002/mds.870110304</idno><idno type="url">https://api.istex.fr/document/E0A2124D53BF6D7E0B6BE559FB3C7F723821814B/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001349</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Clinical course of patients with idiopathic Parkinson's disease</title><author><name sortKey="Roos" sort="Roos" uniqKey="Roos" last="Roos">Roos</name><affiliation><mods:affiliation>Department of Neurology, Leiden University, Leiden, the Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Jongen, J C F" sort="Jongen, J C F" uniqKey="Jongen J" first="J. C. F." last="Jongen">J. C. F. Jongen</name><affiliation><mods:affiliation>Department of Neurology, Leiden University, Leiden, the Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Van Der Velde, E A" sort="Van Der Velde, E A" uniqKey="Van Der Velde E" first="E. A." last="Van Der Velde">E. A. Van Der Velde</name><affiliation><mods:affiliation>Department of Medical Statistics, Leiden University, Leiden, the Netherlands</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1996-05">1996-05</date><biblScope unit="vol">11</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="236">236</biblScope><biblScope unit="page" to="242">242</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">E0A2124D53BF6D7E0B6BE559FB3C7F723821814B</idno><idno type="DOI">10.1002/mds.870110304</idno><idno type="ArticleID">MDS870110304</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Levodopa</term><term>Mortality</term><term>Parkinson's disease</term><term>Survival</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We determined the variables associated with the progression and duration of illness of patients with Parkinson's disease (PD) and investigated the cause of death. In 474 patients with parkinsonism, who visited the Academic Hospital between January 1, 1960 and August 31, 1993, we did a survival analysis with the following covariates: age at onset, intial symptom (tremor or rigidity/hypokinesia), age at reaching Hoehn and Yahr stage III, dementia‐free period, and levodopa treatment. A total of 345 patients with parkinsonism fulfilled the criteria of idiopathic PD; 258 of them were still alive on the closing date of this study. There were significantly more men than women (1.43:1). Medical advice was sought in an earlier stage by men and by patients with tremor as presenting symptom. For patients with rigidity/hypokinesia as first symptom, the duration of illness until reaching Hoehn and Yahr stage III was shorter than for patients starting with tremor alone. If the initial symptom is tremor, patients develop dementia less frequently and later after onset than when tremor is not involved. Reaching Hoehn and Yahr stage III and developing dementia both, limit the patient's survival time. The mortality risk for a patient was found to be increased form the moment levodopa treatment was started as compared to those patients who had not yet started with the treatment. The effect of levodopa on survival could not be disentangled from effects of other factors related to the start of levodopa treatment.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Dr. Roos</name><affiliations><json:string>Department of Neurology, Leiden University, Leiden, the Netherlands</json:string></affiliations></json:item><json:item><name>J. C. F. Jongen</name><affiliations><json:string>Department of Neurology, Leiden University, Leiden, the Netherlands</json:string></affiliations></json:item><json:item><name>E. A. Van Der Velde</name><affiliations><json:string>Department of Medical Statistics, Leiden University, Leiden, the Netherlands</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Survival</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Mortality</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Levodopa</value></json:item></subject><language><json:string>eng</json:string></language><abstract>We determined the variables associated with the progression and duration of illness of patients with Parkinson's disease (PD) and investigated the cause of death. In 474 patients with parkinsonism, who visited the Academic Hospital between January 1, 1960 and August 31, 1993, we did a survival analysis with the following covariates: age at onset, intial symptom (tremor or rigidity/hypokinesia), age at reaching Hoehn and Yahr stage III, dementia‐free period, and levodopa treatment. A total of 345 patients with parkinsonism fulfilled the criteria of idiopathic PD; 258 of them were still alive on the closing date of this study. There were significantly more men than women (1.43:1). Medical advice was sought in an earlier stage by men and by patients with tremor as presenting symptom. For patients with rigidity/hypokinesia as first symptom, the duration of illness until reaching Hoehn and Yahr stage III was shorter than for patients starting with tremor alone. If the initial symptom is tremor, patients develop dementia less frequently and later after onset than when tremor is not involved. Reaching Hoehn and Yahr stage III and developing dementia both, limit the patient's survival time. The mortality risk for a patient was found to be increased form the moment levodopa treatment was started as compared to those patients who had not yet started with the treatment. The effect of levodopa on survival could not be disentangled from effects of other factors related to the start of levodopa treatment.</abstract><qualityIndicators><score>6.337</score><pdfVersion>1.3</pdfVersion><pdfPageSize>576 x 792 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>1516</abstractCharCount><pdfWordCount>3457</pdfWordCount><pdfCharCount>21140</pdfCharCount><pdfPageCount>7</pdfPageCount><abstractWordCount>240</abstractWordCount></qualityIndicators><title>Clinical course of patients with idiopathic Parkinson's disease</title><genre><json:string>Serial article</json:string></genre><host><volume>11</volume><pages><total>7</total><last>242</last><first>236</first></pages><issn><json:string>0885-3185</json:string></issn><issue>3</issue><subject><json:item><value>Article</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>1996</publicationDate><copyrightDate>1996</copyrightDate><doi><json:string>10.1002/mds.870110304</json:string></doi><id>E0A2124D53BF6D7E0B6BE559FB3C7F723821814B</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/E0A2124D53BF6D7E0B6BE559FB3C7F723821814B/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/E0A2124D53BF6D7E0B6BE559FB3C7F723821814B/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/E0A2124D53BF6D7E0B6BE559FB3C7F723821814B/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Clinical course of patients with idiopathic Parkinson's disease</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>1996</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Clinical course of patients with idiopathic Parkinson's disease</title><author><persName><surname>Roos</surname><roleName type="degree">Dr.</roleName></persName><note type="correspondence"><p>Correspondence: Department of Neurology, Leiden University Hospital, P.O. Box 9600, 2300RC Leiden, the Netherlands</p></note><affiliation>Department of Neurology, Leiden University, Leiden, the Netherlands</affiliation></author><author><persName><forename type="first">J. C. F.</forename><surname>Jongen</surname></persName><affiliation>Department of Neurology, Leiden University, Leiden, the Netherlands</affiliation></author><author><persName><forename type="first">E. A.</forename><surname>Van Der Velde</surname></persName><affiliation>Department of Medical Statistics, Leiden University, Leiden, the Netherlands</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1996-05"></date><biblScope unit="vol">11</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="236">236</biblScope><biblScope unit="page" to="242">242</biblScope></imprint></monogr><idno type="istex">E0A2124D53BF6D7E0B6BE559FB3C7F723821814B</idno><idno type="DOI">10.1002/mds.870110304</idno><idno type="ArticleID">MDS870110304</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1996</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>We determined the variables associated with the progression and duration of illness of patients with Parkinson's disease (PD) and investigated the cause of death. In 474 patients with parkinsonism, who visited the Academic Hospital between January 1, 1960 and August 31, 1993, we did a survival analysis with the following covariates: age at onset, intial symptom (tremor or rigidity/hypokinesia), age at reaching Hoehn and Yahr stage III, dementia‐free period, and levodopa treatment. A total of 345 patients with parkinsonism fulfilled the criteria of idiopathic PD; 258 of them were still alive on the closing date of this study. There were significantly more men than women (1.43:1). Medical advice was sought in an earlier stage by men and by patients with tremor as presenting symptom. For patients with rigidity/hypokinesia as first symptom, the duration of illness until reaching Hoehn and Yahr stage III was shorter than for patients starting with tremor alone. If the initial symptom is tremor, patients develop dementia less frequently and later after onset than when tremor is not involved. Reaching Hoehn and Yahr stage III and developing dementia both, limit the patient's survival time. The mortality risk for a patient was found to be increased form the moment levodopa treatment was started as compared to those patients who had not yet started with the treatment. The effect of levodopa on survival could not be disentangled from effects of other factors related to the start of levodopa treatment.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Parkinson's disease</term></item><item><term>Survival</term></item><item><term>Mortality</term></item><item><term>Levodopa</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Article</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1995-10-16">Registration</change><change when="1996-05">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/E0A2124D53BF6D7E0B6BE559FB3C7F723821814B/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="30"><doi origin="wiley" registered="yes">10.1002/mds.v11:3</doi><numberingGroup><numbering type="journalVolume" number="11">11</numbering><numbering type="journalIssue">3</numbering></numberingGroup><coverDate startDate="1996-05">May 1996</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="4" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.870110304</doi><idGroup><id type="unit" value="MDS870110304"></id></idGroup><countGroup><count type="pageTotal" number="7"></count></countGroup><titleGroup><title type="articleCategory">Article</title><title type="tocHeading1">Articles</title></titleGroup><copyright ownership="thirdParty">Copyright © 1996 Movement Disorder Society</copyright><eventGroup><event type="manuscriptAccepted" date="1995-10-16"></event><event type="firstOnline" date="2004-11-04"></event><event type="publishedOnlineFinalForm" date="2004-11-04"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-09"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">236</numbering><numbering type="pageLast">242</numbering></numberingGroup><correspondenceTo>Department of Neurology, Leiden University Hospital, P.O. Box 9600, 2300RC Leiden, the Netherlands</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS870110304.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="3"></count><count type="tableTotal" number="3"></count><count type="referenceTotal" number="22"></count></countGroup><titleGroup><title type="main" xml:lang="en">Clinical course of patients with idiopathic Parkinson's disease</title><title type="short" xml:lang="en">IDIOPATHIC Parkinson's disease</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><honorifics>Dr.</honorifics><givenNames>R. A. C.</givenNames><familyName>Roos</familyName></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>J. C. F.</givenNames><familyName>Jongen</familyName></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af2"><personName><givenNames>E. A.</givenNames><familyName>Van Der Velde</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="NL" type="organization"><unparsedAffiliation>Department of Neurology, Leiden University, Leiden, the Netherlands</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="NL" type="organization"><unparsedAffiliation>Department of Medical Statistics, Leiden University, Leiden, the Netherlands</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Parkinson's disease</keyword><keyword xml:id="kwd2">Survival</keyword><keyword xml:id="kwd3">Mortality</keyword><keyword xml:id="kwd4">Levodopa</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>We determined the variables associated with the progression and duration of illness of patients with Parkinson's disease (PD) and investigated the cause of death. In 474 patients with parkinsonism, who visited the Academic Hospital between January 1, 1960 and August 31, 1993, we did a survival analysis with the following covariates: age at onset, intial symptom (tremor or rigidity/hypokinesia), age at reaching Hoehn and Yahr stage III, dementia‐free period, and levodopa treatment. A total of 345 patients with parkinsonism fulfilled the criteria of idiopathic PD; 258 of them were still alive on the closing date of this study. There were significantly more men than women (1.43:1). Medical advice was sought in an earlier stage by men and by patients with tremor as presenting symptom. For patients with rigidity/hypokinesia as first symptom, the duration of illness until reaching Hoehn and Yahr stage III was shorter than for patients starting with tremor alone. If the initial symptom is tremor, patients develop dementia less frequently and later after onset than when tremor is not involved. Reaching Hoehn and Yahr stage III and developing dementia both, limit the patient's survival time. The mortality risk for a patient was found to be increased form the moment levodopa treatment was started as compared to those patients who had not yet started with the treatment. The effect of levodopa on survival could not be disentangled from effects of other factors related to the start of levodopa treatment.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Clinical course of patients with idiopathic Parkinson's disease</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>IDIOPATHIC Parkinson's disease</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Clinical course of patients with idiopathic Parkinson's disease</title></titleInfo><name type="personal"><namePart type="termsOfAddress">Dr.</namePart><namePart type="family">Roos</namePart><affiliation>Department of Neurology, Leiden University, Leiden, the Netherlands</affiliation><description>Correspondence: Department of Neurology, Leiden University Hospital, P.O. Box 9600, 2300RC Leiden, the Netherlands</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J. C. F.</namePart><namePart type="family">Jongen</namePart><affiliation>Department of Neurology, Leiden University, Leiden, the Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E. A.</namePart><namePart type="family">Van Der Velde</namePart><affiliation>Department of Medical Statistics, Leiden University, Leiden, the Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">article</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">1996-05</dateIssued><dateValid encoding="w3cdtf">1995-10-16</dateValid><copyrightDate encoding="w3cdtf">1996</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">3</extent><extent unit="tables">3</extent><extent unit="references">22</extent></physicalDescription><abstract lang="en">We determined the variables associated with the progression and duration of illness of patients with Parkinson's disease (PD) and investigated the cause of death. In 474 patients with parkinsonism, who visited the Academic Hospital between January 1, 1960 and August 31, 1993, we did a survival analysis with the following covariates: age at onset, intial symptom (tremor or rigidity/hypokinesia), age at reaching Hoehn and Yahr stage III, dementia‐free period, and levodopa treatment. A total of 345 patients with parkinsonism fulfilled the criteria of idiopathic PD; 258 of them were still alive on the closing date of this study. There were significantly more men than women (1.43:1). Medical advice was sought in an earlier stage by men and by patients with tremor as presenting symptom. For patients with rigidity/hypokinesia as first symptom, the duration of illness until reaching Hoehn and Yahr stage III was shorter than for patients starting with tremor alone. If the initial symptom is tremor, patients develop dementia less frequently and later after onset than when tremor is not involved. Reaching Hoehn and Yahr stage III and developing dementia both, limit the patient's survival time. The mortality risk for a patient was found to be increased form the moment levodopa treatment was started as compared to those patients who had not yet started with the treatment. The effect of levodopa on survival could not be disentangled from effects of other factors related to the start of levodopa treatment.</abstract><subject lang="en"><genre>Keywords</genre><topic>Parkinson's disease</topic><topic>Survival</topic><topic>Mortality</topic><topic>Levodopa</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Article</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><detail type="issue"><caption>no.</caption><number>3</number></detail><extent unit="pages"><start>236</start><end>242</end><total>7</total></extent></part></relatedItem><identifier type="istex">E0A2124D53BF6D7E0B6BE559FB3C7F723821814B</identifier><identifier type="DOI">10.1002/mds.870110304</identifier><identifier type="ArticleID">MDS870110304</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 1996 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001349 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001349 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:E0A2124D53BF6D7E0B6BE559FB3C7F723821814B
|texte= Clinical course of patients with idiopathic Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |